483
James W. Findling, M.D.FDA 483 - James W. Findling, M.D. - August 02, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Dr. James Findling, Clinical Investigator, in Milwaukee, WI, from July to August 2019, revealed significant issues with clinical study conduct and IRB reporting. The firm failed to follow the investigational plan regarding subject eligibility, randomization, withdrawal, and dose adjustments. Additionally, the site did not ensure proper IRB oversight by failing to report significant protocol deviations and adverse events in a timely manner.
Open in Dashboard
ID · df56a1cd-739b-4e47-9683-4f1ec20e7fe7